Altimmune reports $31.6 million net loss in Q3
ALT Altimmune Inc
$1.33 -5.67%
View chart & analysis → - 1Altimmune recorded a net loss of $31.6 million in Q3 2026.
- 2Altimmune spent $27 million on research and development (R&D) in Q3 2026.
- 3Altimmune's cash and investment balance of $480 million is expected to provide funding through 2029.
So what's the key point?
Altimmune reported a loss of $31.6 million in the third quarter. While significant funds were spent on research, there is enough cash available to last until 2029.
Source The Motley Fool +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.